Research Paper Volume 14, Issue 13 pp 5571—5589
A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
Figure 13. Identification of candidate drugs targeting the risk signature. (A) Results of CMap analysis. (B–C) Correlation between SLC2A1 expression and predicted drug response. (D) 2D molecular structure diagram of staurosporine. (E) The 3D interaction diagrams of Staurosporine and SLC2A1. *P < 0.05; **P < 0.01; ***P < 0.001.